Adult Still's disease reflects a Th2 rather than a Th1 cytokine profile

Clinical Immunology

Volumn 112, Issue 1, 2004, Pages 120-125

  Saiki, Osamu ^a   Uda, Hiroshi ^a   Nishimoto, Norihiko ^b   Miwa, Takashi ^a   Mima, Toru ^c   Ogawara, Tomoharu ^c   Azuma, Naoto ^c   Katada, Yoshinori ^c   Sawaki, Junko ^d   Tsutsui, Hiroko ^d   Matsui, Kiyoshi ^d   Maeda, Akira ^c   Nakanishi, Kenji ^d  

^a Osaka Prefecture University   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c MINAMI OSAKA GENERAL HOSPITAL   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

ASD; CRP; Cytokine; IL 13; IL 18; IL 4; IL 6; Th1; Th2

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; C-REACTIVE PROTEIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-13; INTERLEUKIN-18; INTERLEUKIN-4; KINETICS; MALE; MIDDLE AGED; STILL'S DISEASE, ADULT-ONSET; TH1 CELLS; TH2 CELLS;

EID: 2942637588     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2004.03.023     Document Type: Article

References (29)

1. Bywaters E.G.L. Still's disease in the adult. Ann. Rheum. Dis. 30:1971;121-133
2. Ohta A., Yamaguchi M., Kaneoka H., Nagayoshi T., Hiida M. Adult Still's disease: review of 228 cases from the literature. J. Rheumatol. 14:1987;1139-1146
3. Pouchot J., Sampalis J.S., Beaudet F., Carette S., Decary F., Salusin-sky-Sternbach M., et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore). 70:1991;118-136
4. Hoshino T., Ohta A., Yang D., Kawamoto M., Kikuchi M., Inoue Y., et al. Elevated serum interleukin 6, interferon-γ, and tumor necrosis factor α levels in patients with adult Still's disease. J. Rheumatol. 25:1998;396-398
5. Stambe C., Wicks I.P. TNF α and response of treatment-resistant adult-onset Still's disease to thalidomide. Lancet. 352:1998;544-545
6. Fujii T., Nojima T., Yasuoka H., Satoh S., Nakamura K., Kuwana M., et al. Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease. Rheumatology. 40:2001;1398-1404
7. Kawashima M., Yamamura M., Taniai M., Yamauchi H., Tanimoto T., Kurimoto M., et al. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum. 44:2001;550-560
8. McInnes I.B., Gracie J.A., Liew F.Y. Interleukin 18: a novel cytokine in inflammatory rheumatic disease. Arthritis Rheum. 44:2001;1481-1483
9. Okumura H., Nagata K., Komatsu T., Nukata Y., Tanabe F., et al. A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect. Immun. 63:1995;3966-3972
10. Okumura H., Tsutsi H., Komatsu Yutsudo M., Hakura A., Tanimoto T., et al. Cloning of a new cytokin that induce IFN-γ production by T cells. Nature. 378:1995;88-91
11. Ushio S., Namba M., Okura T., Hattori K., Nukada Y., Akita K., et al. Cloning of the cDNA for human INF-γ-inducing factor, expressing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J. Immunol. 156:1996;4274-4279
12. Okamura H., Tsutsi H., Kashiwamura S., Yoshimoto T., Nakanishi K. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 70:1998;281-312
13. Dinarello C.A., Novick D., Puren A.J., Fantuzzi G., Shapiro L., Muhl H., et al. Overview of interleukin-18: more than interferon-gamma inducing factor. J. Leukocyte Biol. 63:1998;658-664
14. Okamura H., Kashiwamura S., Tsutsui H., Yoshimoto T., Nakanishi K. Regulation of interferon-γ production by IL-12 and IL-18. Curr. Opin. Immunol. 10:1998;259-264
15. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19:2001;423-474
16. Cush J.J., Medsger T.A. Jr., Christy W.C., Herbert D.C., Cooperstein L.A. Adult-onset Still's disease: clinical course and outcome. Arthritis Rheum. 30:1987;186-194
17. Yamaguchi M., Ohta A., Tsunematsu T., Kasukawa R., Mizushima Y., Kashiwagi H., et al. Preliminary criteria for classification of adult Still's disease. J. Rheumatol. 19:1992;424-430
18. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:1988;315-324
19. Saiki O., Kawamoto M., Fukuzumi M., Kanou M., Utsumi S. Staphylococcus Wood 46 strain activates human B cells without affecting DNA synthesis or tyrosine phosphorylation. J. Immunol. 150:1993;3224-3229
20. Gracie J.A., Forsey R.J., Chan W.L., Gilmour A., Leung B.P., Greer M.R., et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J. Clin. Invest. 104:1999;1393-1401
21. E.H.S. Choy, G.S. Panayi, Cytokine pathways and joint inflammation in rheumatoid arthritis. New Engl. J. Med. 344 907-16.
22. Dolhain R.J.E.M., van der Heiden A.N., ter Haar N.T., Breedveld F.C., Miltenburg A.M.M. Shift toward T lymphocytes with a helper 1 cytokine-secretion profile in the joint of patients with rheumatoid arthritis. Arthritis Rheum. 39:1996;1961-1969
23. Simon A.K., Seipelt E., Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc. Natl. Acad. Sci. U. S. A. 91:1994;8526
24. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 12:2001;53-72
25. Yoshimoto T., Mizutani H., Tsutsui H., Noben-Trauth N., Yamanaka K., Tanaka M., et al. IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nat. Med. 1:2000;132-137
26. Pizzaro T.T., Michie M.H., Bentz M., Woraratanadharm J., Smith M.F. Jr., Foley E., et al. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J. Immunol. 162:1999;6829-6835
27. McCarty M.F. Reduction of serum C-reactive protein by statin therapy may reflect decreased isophenylation of Rac 1, a mediator of the IL-6 signal transduction pathway. Med. Hypotheses. 60:2003;634-639
28. Yokoi K., Hosoi E., Nakanishi M., Goto T., Saito S. Increased serum IgE level and interleukin-4 release from cultured lymphocytes from a patient with adult onset Still's disease. Ann. Rheum. Dis. 54:1995;752-753
29. Yoshimoto T., Min B., Sugimoto T., Hayashi N., Ishikawa Y., Sasaki Y., et al. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+T cells in the induction of immunoglobulinE antibodies in response to interleukin 18 treatment of mice. J. Exp. Med. 197:2003;997-1005